Vir Biotechnology, Inc.
VIR
$5.63
-$0.44-7.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -78.55% | -75.91% | -73.79% | -13.90% | -33.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.55% | -75.91% | -73.79% | -13.90% | -33.82% |
| Cost of Revenue | -9.88% | 9.67% | -2.18% | -15.78% | -20.29% |
| Gross Profit | -2.77% | -27.61% | -10.82% | 16.11% | 17.16% |
| SG&A Expenses | -28.75% | -33.66% | -34.96% | -31.76% | -22.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.82% | -1.00% | -10.06% | -19.48% | -20.72% |
| Operating Income | 4.74% | -10.25% | 1.64% | 20.20% | 18.46% |
| Income Before Tax | 7.38% | -11.72% | -5.28% | 16.73% | 18.19% |
| Income Tax Expenses | 104.59% | 103.00% | 86.71% | 91.24% | 89.98% |
| Earnings from Continuing Operations | 6.32% | -13.91% | -7.08% | 15.14% | 11.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | 6.32% | -13.91% | -7.08% | 15.14% | 11.21% |
| EBIT | 4.74% | -10.25% | 1.64% | 20.20% | 18.46% |
| EBITDA | 4.06% | -11.85% | 0.76% | 20.05% | 18.81% |
| EPS Basic | 7.74% | -12.10% | -5.24% | 16.56% | 12.57% |
| Normalized Basic EPS | 1.01% | -16.48% | -1.11% | 22.76% | 26.11% |
| EPS Diluted | 7.84% | -11.97% | -5.12% | 16.64% | 12.47% |
| Normalized Diluted EPS | 1.01% | -16.48% | -1.11% | 22.76% | 26.11% |
| Average Basic Shares Outstanding | 1.64% | 1.66% | 1.66% | 1.58% | 1.44% |
| Average Diluted Shares Outstanding | 1.64% | 1.66% | 1.66% | 1.58% | 1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |